China Health Group Inc. (HKG:8225)

China Health Group Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	33.85	21.82	14.19	4.14	4.06	11.36
Trading Asset Securities	1.72	1.72	1.7	3.16	8.01	5.66
Cash & Short-Term Investments	35.57	23.54	15.89	7.3	12.07	17.02
Cash Growth	39.90%	48.13%	117.57%	-39.50%	-29.10%	-39.96%
Accounts Receivable	49.66	42.12	57.58	65.4	108.82	128.51
Other Receivables	-	-	-	-	0.06	2.03
Receivables	49.66	42.12	57.58	65.4	108.89	130.54
Other Current Assets	6.52	13.81	19.16	39.48	56.27	45.21
Total Current Assets	91.75	79.47	92.64	112.18	177.23	192.78
Property, Plant & Equipment	2.14	2.32	2.73	7.17	1.4	1.55
Other Long-Term Assets	5.15	5.28	5.6	-	-	-
Total Assets	99.05	87.08	100.96	119.35	178.63	194.33

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	10.14	0.43	0.49	5.54	5.78	7.1
Accrued Expenses	-	5.2	3.97	3.2	3.83	5.2
Current Income Taxes Payable	23.57	21.89	21.93	22.08	22.15	22.52
Current Unearned Revenue	1.08	1.01	1.01	1.01	1.01	1.01
Other Current Liabilities	-	3.78	3.84	3.33	3.96	2.93
Total Current Liabilities	34.79	32.32	31.24	35.17	36.74	38.75
Total Liabilities	34.79	32.32	31.24	35.17	36.74	38.75

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	88.91	88.91	88.91	88.91	88.91	88.91
Additional Paid-In Capital	7.63	7.63	7.63	7.63	7.63	7.63
Retained Earnings	-40.23	-49.72	-36.86	-22.68	34.77	50.15
Comprehensive Income & Other	8.58	8.58	10.68	10.96	11.01	8.88
Total Common Equity	64.89	55.39	70.35	84.82	142.32	155.57
Minority Interest	-0.64	-0.64	-0.64	-0.64	-0.44	-
Shareholders' Equity	64.25	54.76	69.72	84.18	141.88	155.57
Total Liabilities & Equity	99.05	87.08	100.96	119.35	178.63	194.33

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Cash (Debt)	35.57	23.54	15.89	7.3	12.07	17.02
Net Cash Growth	39.90%	48.13%	117.57%	-39.50%	-29.10%	-36.60%
Net Cash Per Share	0.04	0.02	0.02	0.01	0.01	0.02
Filing Date Shares Outstanding	995.35	995.35	995.35	995.35	995.35	995.35
Total Common Shares Outstanding	995.35	995.35	995.35	995.35	995.35	995.35
Working Capital	56.96	47.15	61.39	77.01	140.48	154.02
Book Value Per Share	0.07	0.06	0.07	0.09	0.14	0.16
Tangible Book Value	64.89	55.39	70.35	84.82	142.32	155.57
Tangible Book Value Per Share	0.07	0.06	0.07	0.09	0.14	0.16
Machinery	-	19.36	19.35	23.04	17.58	17.58
Construction In Progress	-	0.05	0.05	0.05	0.05	0.05
Leasehold Improvements	-	-	-	0.54	-	1.12

Data Source: S&P Global Market Intelligence Last updated: Aug 27, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 27, 2026

Data Sources Report a data error